October 20, 2020
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process.
The platform was designed for LabCorp’s drug development and decentralized clinical trial business, Covance. It hopes to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use...
July 27, 2020
On Friday evening, the FDA reissued an emergency use authorization (EUA) for LabCorp's COVID-19 RE-PCR Test that now allows for testing among those without any symptoms of COVID-19.
The agency also expanded the indication to allow for pooled sample testing – a technique of combining multiple samples into a single test, and then following up with individual tests should the group be positive. The...
May 28, 2020
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
April 21, 2020
Thanks to an updated emergency use authorization (EUA) from the FDA, LabCorp's COVID-19 RT-PCR test is now the first diagnostic test for COVID-19 that permits at-home sample collection.
Now, patients may use Q-tip-style nasal cotton swabs and saline included in LabCorp's designated self-collection kit – which the company is branding as the "Pixel by LabCorp COVID-19 Test." These samples are...
April 9, 2020
Yesterday, maternity-care-management platform Dorsata scored $5.2 million in Series A funding. Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital participated in this round.
WHAT THEY DO
Dorsata entered the market in late 2017, with its tool designed to help prevent variations in medical care during maternity and decrease the rate of preventable complications.
November 1, 2018
Clinical lab and life science services company LabCorp has signaled its latest consumer-focused shift with the announcement of a self-administered wellness test and online results portal.
Called Pixel by LabCorp, the testing platform is ordered online by consumers, reviewed by a board-certified physician and then delivered to the consumer within a few days. After collecting a blood sample using...
May 3, 2017
San Francisco-based telemedicine provider Doctor on Demand has added another layer to its virtual visits with the integration of laboratory services with Quest Diagnostics and LabCorp, which will be available in the coming months.
Rather than interrupt their service and create additional paperwork or communication chains, clinicians practicing with Doctor on Demand can continue playing the...
November 25, 2014
Plano, Texas-based remote patient monitoring company Vivify Health has raised the first tranche of funding in what the company expects to be a $15 million round. Strategic investors Laboratory Corporation of America Holdings (LabCorp) and Envision Healthcare Holdings were the primary investors in the round, which follows on the company's $7 million round of funding led by two other strategic...
June 25, 2013
Keas, the corporate wellness platform founded by Google Health vet Adam Bosworth in 2009, has announced an $8 million investment round, new customers and partners. The round was led by existing partners Atlantic Ventures and Ignition Partners. Keas hasn't raised money since the end of 2011, when it raised $6.5 million. Total funding for the company now stands at $25.5 million.